Last reviewed · How we verify
NCT06892418
Impact of Ketoflex 12/3 Diet on Parkinson's Disease Symptoms: A Clinical Study
NA trial testing Ketoflex 12/3 Diet in Parkinson's Disease in 40 participants. Completed in 30 November 2024.
30 October 2024
Quick facts
| Lead sponsor | Istanbul Medipol University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 40 |
| Start date | 30 March 2024 |
| Primary completion | 30 October 2024 |
| Estimated completion | 30 November 2024 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Ketoflex 12/3 Diet
Conditions studied
- Parkinson's Disease — all drugs for Parkinson's Disease →
- Parkinson — all drugs for Parkinson →
Sponsor
Istanbul Medipol University Hospital
Who can join
Adults 40 to 85, any sex, with Parkinson's Disease or Parkinson. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate the effects of the Ketoflex 12/3 diet on motor and non-motor symptoms in patients with Parkinson's disease. Participants will follow the Ketoflex 12/3 dietary regimen, and their cognitive function, motor symptoms, sleep patterns, gastrointestinal health, and overall well-being will be assessed through standardized clinical scales. The study will help determine whether a plant-based ketogenic diet combined with intermittent fasting can have a beneficial impact on Parkinson's disease progression.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06892418
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ketoflex 12/3 Diet
Trials testing the same drug.
- NCT06898424 — Impact of Ketoflex 12/3 Diet on Early-to-Mid Stage Alzheimer's Progression · NA · completed
Other recruiting trials for Parkinson's Disease
Currently open trials in the same condition.
- NCT07115394 — EEG Measurements to Capture DBS-induced Electric Potentials · recruiting
- NCT07100171 — Evaluation of GM101 Injection in Patients With Parkinson's Disease · EARLY_PHASE1 · recruiting
- NCT06701955 — Study of the Test-retest Reliability of the Neuropsychiatric Fluctuations Scale in Parkinson's Disease · NA · recruiting
Other Istanbul Medipol University Hospital trials
Trials by the same sponsor.
- NCT07508371 — Menthol Massage for Post-Bypass Pain & Anxiety · NA · not yet recruiting
- NCT07575477 — Comparison Of Early Mobilization And Electrical Stimulation On Functional Recovery After Lumbar Disc Herniation Surgery · NA · not yet recruiting
- NCT07525115 — Effects of Proprioceptive Neuromuscular Facilitation-Based Lower Extremity Training on Balance, Gait, and Functional Ind · NA · not yet recruiting
- NCT07467278 — Low-FODMAP Diet and Intestinal Permeability in Patients With Irritable Bowel Syndrome · NA · not yet recruiting
- NCT07468864 — Validity of the Turkish Situational Vertigo Questionnaire · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06892418 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Istanbul Medipol University Hospital
- Last refreshed: 2 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06892418.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing